BioCentury
ARTICLE | Clinical News

IV Carbella carbamazepine regulatory update

March 17, 2014 7:00 AM UTC

H. Lundbeck said FDA accepted for review an NDA for IV Carbella carbamazepine as replacement therapy in adults who are on a stable maintenance oral dose of carbamazepine to control certain seizure typ...